PW Medtech GroupFRA:PWE -1.82%83 FCF Yield % is 9.48 as of Jun. 30, 2026, which is 222% above its 10-year median of 2.94. GuruFocus rates FRA:PWE with a GF Score™ of 83/100 and a GF Value™ of €0.13. The stock has 5 warning signs investors should review. Among 854 Medical Devices & Instruments companies, PW Medtech Group ranks better than 92.74% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for PW Medtech Group's FCF Yield % or its related term are showing as below:
FRA:PWE'
s FCF Yield % Range Over the Past 10 Years
Min: -5.62 Med: 2.94 Max: 28.99
Current: 9.48
During the past 13 years, the highest FCF Yield % of PW Medtech Group was 28.99%. The lowest was -5.62%. And the median was 2.94%.
FRA:PWE's FCF Yield % is ranked better than 92.74% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: -0.385
vs FRA:PWE: 9.48
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
PW Medtech Group FCF Yield % Related Terms
PW Medtech Group FCF Yield % Historical Data
* Premium members only.
The historical data trend for PW Medtech Group's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:PWE vs ISRG, BDX, MDLN: FCF Yield % Comparison
For the Medical Instruments & Supplies subindustry, PW Medtech Group's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PW Medtech Group FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PW Medtech Group's FCF Yield % distribution charts can be found below:
* The bar in red indicates where PW Medtech Group's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PW Medtech Group (FRA:PWE) has a FCF Yield % of 9.48 as of Jun. 30, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on PW Medtech Group and its competitors. This is 222% above median its historical median of 2.94. According to the industry distribution chart, PW Medtech Group ranks #62 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 7.3%.
Is PW Medtech Group's FCF Yield % too high?
PW Medtech Group's current FCF Yield % of 9.48 is 222% above median its 10-year median of 2.94. Based on the distribution chart, PW Medtech Group ranks #62 out of 854 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, PW Medtech Group has a GF Score™ of 83/100, reflecting its overall financial health beyond just this single metric.
How does PW Medtech Group's FCF Yield % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, PW Medtech Group ranks #62 out of 854 companies for FCF Yield %. This places PW Medtech Group in the top 7% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on PW Medtech Group and its competitors. PW Medtech Group's current FCF Yield % is 9.48, which is 222% above median its own 10-year median of 2.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PW Medtech Group stock overvalued right now?
PW Medtech Group (FRA:PWE) has a current FCF Yield % of 9.48. The stock's GF Value™ is €0.13, compared to a current price of €0.11 — trading 16.9% below its estimated fair value. The current FCF Yield % is 9.48, which is 222% above median its 10-year median of 2.94. PW Medtech Group's overall GF Score™ is 83/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For PW Medtech Group (FRA:PWE), the current FCF Yield % is 9.48 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PW Medtech Group (FRA:PWE) Overvalued in 2026?
Based on GuruFocus' analysis, PW Medtech Group stock appears to be undervalued.
The current stock price of €0.11 is trading 16.9% below its estimated GF Value™ of €0.13.
Key valuation signals for FRA:PWE:
FCF Yield %: 9.48 (222% above median its 10-year median of 2.94)
GF Value™: €0.13 vs. price of €0.11 (16.9% below fair value)
No single metric tells the full story. See the FRA:PWE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PW Medtech Group Ltd is a medical device company focused on China's medical device industry. The Group operates in infusion sets, blood purification products, and regenerative medical biomaterials. Its products include non-PVC-based infusion sets, precision filter infusion sets, light-resistant infusion sets, intravenous cannula products, insulin needles and pens, high flux and low flux hemodialyzers, hemodiafilters, hemoperfutors, and dialysis machines. Its segments are Infusion Set Business, Blood Purification Business, which represents the R&D, manufacturing, and sales of hemodialysis and blood purification medical devices, and Regenerative Medical Biomaterials Business, which generates maximum revenue. Geographically, it operates in China, North America, India and Others.
83GF Score
Get the complete analysis for FRA:PWE
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PWE has been successfully added to your 
